Cleveland Cell Therapy Incubator selected as production hub for Deverra’s cord-blood derived therapeutics CLEVELAND and SEATTLE, April 5, 2022 /PRNewswire/ — Deverra Therapeutics, Inc., a leading clinical-stage company in Seattle, Washington, developing therapeutic allogeneic…
News Ticker
- [ September 29, 2023 ] Health research funding to Oregon slowed in 2022 News
- [ September 29, 2023 ] Legacy doctors and nurse practitioners file for union recognition News
- [ September 29, 2023 ] Exclusive: Former Genentech duo reunites to push Sonoma into the clinic; Ex-Magenta commercial chief heads to Editas News
- [ September 29, 2023 ] Sonoma Biotherapeutics Appoints Joseph R. Arron, M.D., Ph.D., as Chief Scientific Officer and Mark D. Eisner, M.D., MPH, as Chief Medical Officer News
- [ September 29, 2023 ] Associate Director, Bioassays – Absci – Vancouver, WA Jobs
Copyright © 2023 Biotech Networks, LLC
